MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis.
OBJECTIVES:MET is a receptor present in the membrane of NSCLC cells and is known to promote cell proliferation, survival and migration. MET gene copy number is a common genetic alteration and inhibition o MET emerges as a promising targeted therapy in NSCLC. Here we aim to combine in a meta-analysis...
Main Authors: | Anastasios Dimou, Lemuel Non, Young Kwang Chae, William J Tester, Konstantinos N Syrigos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4169409?pdf=render |
Similar Items
-
The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment
by: Anastasios Dimou, et al.
Published: (2020-07-01) -
Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
by: Jin Sheng, et al.
Published: (2016-01-01) -
Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
by: Yanqiu Wang, et al.
Published: (2019-03-01) -
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.
by: Raquel Jorge Ferreira Catarino
Published: (2019) -
Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.
by: Raquel Catarino, et al.
Published: (2012-01-01)